Orchid Pharma and Cipla partner to distribute Orchid's new antibiotic, Cefepime-Enmetazobactam, in India.

Orchid Pharma and Cipla partner to distribute Orchid's new antibiotic, Cefepime-Enmetazobactam, approved for treating cUTI, HAP, and VAP. The collaboration leverages Orchid's innovation in drug development and Cipla's robust distribution network to efficiently deliver the life-saving drug to healthcare providers across India. The partnership addresses urgent global healthcare issues, including antimicrobial resistance.